Timely reflection in here on the challenge of realising AI benefits across discovery. Because success is a product of correct decision making across many different disciplines it’s easy to get carried away with newer technical advantages that are not guaranteed to translate
Everyone said AI would eat biology.
A decade later, AI is the one getting indigestion.
Here’s what actually happened - and what the new wave of GenAI biotechs need to learn:
🧵 1/
We're exhibiting on the UK Pavilion (Hall A, Stand 765) at #BIO2025.
Use the BIO Business Partnering System to book a meeting with us if you need #outsourced drug discovery & development support.
Dr. David Mosedale from @RxCelerate will be a guest speaker at our #ScientificConference on 25 June.
Don't miss his presentation discussing his work surrounding patients with Crohn's Disease.
Reserve your spot now: https://t.co/xqHwEgdZgC
Less than a month to go until #BIO2025!
We're co-exhibitors on the UK Pavilion (Stand 765, Hall A), organised by @biztradegovuk to showcase the strength and innovation of the UK’s #lifesciences sector.
Arrange to meet us via the BIO partnering app or email [email protected]
If you're on Campus today head to the Market Restaurant before 3pm to speak with the @RxCelerate team and find out more about how the range of services they offer could support your science.
We’ve been shortlisted for two awards at the 2025 @CambridgeIndy Science and Technology Awards!
RxCelerate is a finalist for:
🏆 Biotech Company of the Year
🏆 Employer of the Year
See the full list here:
https://t.co/lZTBHULJhY
#SciTechAwards#CambridgeBiotech
Last year we completed a number of projects with @bitbio, our neighbours @BabrahamUK, providing services from our in vitro, preclinical, and histology teams
We greatly appreciate this feedback from Will and look forward to working with them again soon
🖱️https://t.co/BU9km8t7Sg
Our Head of Molecular Modelling, Joao, shares what he loves about being part of our #insilico team.
Find out more about RxCelerate's in silico capabilities here: https://t.co/AjAkow8Ke5
Season’s Greetings from all of us at RxCelerate!
This month has been filled with festive cheer, from team lunches and our Christmas party to enjoying carols, Christmas crafting, and board games together. 🎄✨
Amy & Nicola are representing RxCelerate at #GenesisLondon2024 today. They're enjoying the Life Science presentations, panels, and networking opportunities, discussing our innovative drug discovery and development solutions.
🖱️https://t.co/BU9km8sA2I
By combining integrated teams with our unique technologies, we’ll design the right strategy to drive your asset through drug discovery, preclinical research and beyond.
Find out more: https://t.co/vbFWczKQwu
#drugdiscovery#biotech
“Fast and seamless…enabling us to deliver key objectives faster”
We’re really grateful to Aurore at Xap Therapeutics for sharing her experience of working with our Biology teams.
Find out more about these services and more on our website: https://t.co/BU9km8t7Sg
The team is excited to attend BIO-Europe next week! You’ll find us at Booth 140.
Get in touch to discuss how we can support your drug discovery and development journey.
See our full range of services here: https://t.co/BU9km8sA2I
#BIOEurope#DrugDevelopment
We've worked with @JHuntingtonUCam on many #drugdiscovery and development projects over the past 10 years.
We’re grateful for his kind words on what makes RxCelerate unique.
Find out more about our full range of services: https://t.co/BU9km8sA2I
We’re excited to attend @ELRIG_UK #DrugDiscovery2024 again this year! Come and meet the team at Booth 35 to find out more about the services we offer and how RxCelerate can support your drug discovery and development projects ⭐️
Thrilled to share our work on novo protein LYTAC(pLYTAC)/EndoTag in @nature! Using de novo protein design, we created endocytosis triggering binding proteins (EndoTags) to degrade extracellular targets and amplify receptor signaling. https://t.co/lN8NdT8904